ATE245196T1 - Regulierung der fruchtbarkeit mit transformierendem wachstumfaktor beta - Google Patents

Regulierung der fruchtbarkeit mit transformierendem wachstumfaktor beta

Info

Publication number
ATE245196T1
ATE245196T1 AT94911509T AT94911509T ATE245196T1 AT E245196 T1 ATE245196 T1 AT E245196T1 AT 94911509 T AT94911509 T AT 94911509T AT 94911509 T AT94911509 T AT 94911509T AT E245196 T1 ATE245196 T1 AT E245196T1
Authority
AT
Austria
Prior art keywords
growth factor
transforming growth
factor beta
fertility
regulation
Prior art date
Application number
AT94911509T
Other languages
English (en)
Inventor
Ronald F Feinberg
Harvey Jon Kliman
Original Assignee
Univ Pennsylvania
Univ Yale
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Pennsylvania, Univ Yale filed Critical Univ Pennsylvania
Application granted granted Critical
Publication of ATE245196T1 publication Critical patent/ATE245196T1/de

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18Growth factors; Growth regulators
    • A61K38/1841Transforming growth factor [TGF]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475Assays involving growth factors
    • G01N2333/495Transforming growth factor [TGF]
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/36Gynecology or obstetrics
    • G01N2800/367Infertility, e.g. sperm disorder, ovulatory dysfunction
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/806Fertility tests
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/811Test for named disease, body condition or organ function
    • Y10S436/814Pregnancy
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/906Fertility tests

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT94911509T 1993-03-10 1994-03-08 Regulierung der fruchtbarkeit mit transformierendem wachstumfaktor beta ATE245196T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/029,027 US5395825A (en) 1993-03-10 1993-03-10 Fertility regulation with transforming growth factor β
PCT/US1994/002527 WO1994020637A1 (en) 1993-03-10 1994-03-08 Fertility regulation with transforming growth factor beta

Publications (1)

Publication Number Publication Date
ATE245196T1 true ATE245196T1 (de) 2003-08-15

Family

ID=21846834

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94911509T ATE245196T1 (de) 1993-03-10 1994-03-08 Regulierung der fruchtbarkeit mit transformierendem wachstumfaktor beta

Country Status (9)

Country Link
US (2) US5395825A (de)
EP (1) EP0688365B1 (de)
JP (1) JPH08507530A (de)
AT (1) ATE245196T1 (de)
AU (1) AU676727B2 (de)
CA (1) CA2156613A1 (de)
DE (1) DE69432951T2 (de)
DK (1) DK0688365T3 (de)
WO (1) WO1994020637A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5508045A (en) * 1992-10-09 1996-04-16 The Regents Of The University Of California Method and agents for control and management of labor during pregnancy
US5830848A (en) * 1992-10-09 1998-11-03 The Regents Of The University Of California Method and agents for inducement of endogenous nitric oxide synthase for control and management of labor during pregnancy
US5395825A (en) * 1993-03-10 1995-03-07 Yale University Fertility regulation with transforming growth factor β
US5599918A (en) * 1994-10-04 1997-02-04 La Jolla Cancer Research Foundation Nucleic acids encoding trophinin and trophinin-assisting proteins
US5654145A (en) * 1994-10-04 1997-08-05 La Jolla Cancer Research Foundation Trophinin and trophinin-assisting nucleic acids and methods of detection thereof
US6309843B1 (en) 1994-10-25 2001-10-30 The Curators Of The University Of Missouri Glycoprotein for use in determining endometrial receptivity
US7211644B1 (en) * 1996-08-27 2007-05-01 University Of South Florida Diagnostic markers of human female infertility
US6683156B1 (en) 1996-08-27 2004-01-27 University Of South Florida Method for diagnosing selected adenocarcinomas
US8106001B2 (en) * 1996-08-27 2012-01-31 University Of South Florida Diagnostic markers of human female infertility
US6294662B1 (en) 1996-08-27 2001-09-25 University Of South Florida Nucleic acids encoding an endometrial bleeding associated factor (ebaf)
AUPO550897A0 (en) * 1997-03-06 1997-03-27 Luminis Pty Limited Treatment and diagnosis of an infertility condition
AU722150B2 (en) * 1997-03-06 2000-07-20 University Of Adelaide, The Treatment and diagnosis of infertility using TGFbeta or activin
US6300311B1 (en) 1998-04-14 2001-10-09 Texas Tech University Regulation of vertebrate ovarian maturation and function using growth factors
AU3671499A (en) * 1998-04-29 1999-11-16 University Of South Florida Diagnostic markers of human female infertility
GB0201284D0 (en) * 2002-01-21 2002-03-06 Isis Innovation Screening methods for contraceptive and fertility agents
US7572639B2 (en) * 2004-06-03 2009-08-11 Stc.Unm Method and apparatus for predicting pregnancy outcome
CA2575675A1 (en) 2004-07-30 2006-03-09 Adeza Biomedical Corporation Oncofetal fibronectin as a marker for disease and other conditions and methods for detection of oncofetal fibronectin
WO2011002251A2 (ko) * 2009-07-01 2011-01-06 중앙대학교 산학협력단 수태능력 예측용 마커
GB201314452D0 (en) * 2013-08-13 2013-09-25 Ostara Biomedical Ltd Embryo implantation

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5104977A (en) * 1982-09-24 1992-04-14 The United States Of America As Represented By The Department Of Health And Human Services Purified transforming growth factor beta
US4894326A (en) * 1986-04-09 1990-01-16 Fred Hutchinson Cancer Research Center Monoclonal antibody defining oncofetal structure of fibronectin
US5098890A (en) * 1988-11-07 1992-03-24 Temple University-Of The Commonwealth System Of Higher Education Antisence oligonucleotides to c-myb proto-oncogene and uses thereof
US5158934A (en) * 1989-09-01 1992-10-27 Genentech, Inc. Method of inducing bone growth using TGF-β
FI921353A7 (fi) * 1989-09-29 1992-03-27 La Jolla Cancer Res Foundation Tranformoiva kasvutekijä b:n inhibointi solunulkoisen matriisin kertym isen ehkäisemiseksi
US5276017A (en) * 1990-09-14 1994-01-04 Trustees Of The University Of Pennsylvania Therapeutic and diagnostic applications of tropho-uteronectin (TUN) manipulation
US5395825A (en) * 1993-03-10 1995-03-07 Yale University Fertility regulation with transforming growth factor β
FR2720069A1 (fr) * 1994-05-19 1995-11-24 Inst Nat Sante Rech Med Dérivés de facteurs de croissance et d'hormones de la superfamille des TGFB, procédé pour leur obtention et leurs applications biologiques.

Also Published As

Publication number Publication date
CA2156613A1 (en) 1994-09-15
WO1994020637A1 (en) 1994-09-15
AU676727B2 (en) 1997-03-20
EP0688365B1 (de) 2003-07-16
US5395825A (en) 1995-03-07
AU6399894A (en) 1994-09-26
EP0688365A1 (de) 1995-12-27
JPH08507530A (ja) 1996-08-13
DK0688365T3 (da) 2003-09-29
DE69432951D1 (de) 2003-08-21
EP0688365A4 (de) 1997-06-25
DE69432951T2 (de) 2004-05-13
US5693479A (en) 1997-12-02

Similar Documents

Publication Publication Date Title
ATE245196T1 (de) Regulierung der fruchtbarkeit mit transformierendem wachstumfaktor beta
MY102705A (en) Proline derivaties and related compounds.
YU48666B (sh) Mometason furoat monohidrat i postupak za njegovo dobijanje
IL110672A0 (en) Therapeutic heterocycles
AU2332288A (en) Compounds having antiprogestational and anti-estrogenic activities for induction of labor and for termination of pregnancy, as well as for the treatment of gynaecological disorders
ES2124250T3 (es) Anticuerpo especifico para un antigeno tumoral.
ES466793A1 (es) Un procedimiento para la preparacion de derivados de imida- zol, con propiedades antiartriticas.
GR890100033A (el) Μέ?οδος παρασκευής διδεοξυδιδευδροκαρβοκυκλικών νουκλεοσιδών.
UA32409C2 (uk) Згинальний пристрій
BG40815A3 (bg) Метод за получаване на пептиди
ES533261A0 (es) Procedimiento para la preparacion de 1-alquil-androsta-1,4-dien-3,17-dionas
SE8003263L (sv) Ledbeslag for seten med instellbar lutning, serskilt fordonsseten
ES2109103T3 (es) Procedimiento para la preparacion de trialquilsilil-7 bacatina iii.
BG36928A3 (bg) Метод за получаване на фармакологично активни пептиди
GB1531176A (en) Hydrogenated imidazothiazine derivatives
MX9303843A (es) 4-iminoquinolinas, procedimiento para su preparacion y su empleo.
ES2099820T3 (es) Procedimiento para la preparacion de trans-piperidina-2,5-dicarboxilatos.
ES2165350T3 (es) Descarboxilasa de acido glutamico clonada.
ATE227122T1 (de) Stabilisierte tablettenformulierung
ES8704469A1 (es) Procedimiento para preparar naftoxacinas
ES8205218A1 (es) Un procedimiento para la preparacion de pirrolilpiperidinas utiles como agentes antidepresivo.
GR3005231T3 (de)
MX9300677A (es) Procedimiento mejorado para la preparacion de dienos esteroidales substituidos.
SU887878A1 (ru) Демпфирующее устройство
FI890173L (fi) Isoxazoler med nootropisk verkan.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties